[Effect of tiemonium iodide (Visceralgine) on the ureteral contractile activities and its clinical use in urology].
D000328:Adult; D000368:Aged; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007273:Injections, Intramuscular; D007454:Iodides / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D009119:Muscle Contraction / Q000187:drug effects*; D010276:Parasympatholytics / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use; D014398:Tuberculosis, Renal / Q000188:drug therapy; D014513:Ureter / Q000187:drug effects*; D014570:Urologic Diseases / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy
D007454:Iodides; D009025:Morpholines; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D013876:Thiophenes